From Google Scholar+ [to 2 November 2013]

From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary

Association between health care workers’ knowledge of influenza vaccine and vaccine uptake
O Jaiyeoba, M Villers, DE Soper, J Korte, CD Salgado – American Journal of Infection …, 2013

Methods Vaccination was voluntary at our institution prior to 2010 and resulted in compliance rates ranging from 40% to 60%. Our institution adopted a policy for the 2010-2011 season and beyond that stated all employees who refused vaccine were required to …

Immunosignatures can predict vaccine efficacy
JB Legutki, SA Johnston – Proceedings of the National Academy of Sciences, 2013
Abstract The development of new vaccines would be greatly facilitated by having effective methods to predict vaccine performance. Such methods could also be helpful in monitoring individual vaccine responses to existing vaccines. We have developed “ …

Health disparities in human papillomavirus vaccine coverage: Trends analysis from NIS-Teen, 2008-2011
RA Bednarczyk, EA Curran, WA Orenstein, SB Omer – Clinical Infectious Diseases, 2013
Abstract Adolescent uptake of human papillomavirus (HPV) vaccine remains low. We evaluated HPV vaccine uptake patterns over 2008-2011 by race/ethnicity, poverty status, and the combination of race/ethnicity and poverty status, utilizing National Immunization …

[HTML] A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA. HIVA Administered to Gambian Infants
MO Afolabi, J Ndure, A Drammeh, F Darboe… – PLOS ONE, 2013
Background A vaccine to decrease transmission of human immunodeficiency virus type 1 (HIV-1) during breast-feeding would complement efforts to eliminate infant HIV-1 infection by antiretroviral therapy. Relative to adults, infants have distinct immune development, …

A systems framework for vaccine design
M Mooney, S McWeeney, G Canderan, RP Sékaly – Current Opinion in Immunology, 2013
Numerous challenges have been identified in vaccine development, including variable efficacy as a function of population demographics and a lack of characterization and mechanistic understanding of immune correlates of protection able to guide delivery and …

Special Focus Newsletters
November 1, 2013
Lead story
Burkina Faso takes on burden of diarrhea and pneumonia together
Dual vaccine launch follows success of MenAfriVac® introduction

A Non-State Centric Governance Framework for Global HealthBarcelona Institute for Global Health
A Global Social Contract for a Healthy Global Society: Why, What and HowBarcelona Institute for Global Health